NATCO invests US$ 2 million in Cellogen Therapeutics
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
People in India are still wary of organ transplants. So, there is an urgent need of increased public awareness.
Subscribe To Our Newsletter & Stay Updated